If you are not able to view this e-mail properly, please click here to view it online
World Pharma Today Maqazine
World Pharma Today Linkedin Page World Pharma Today Facebook Page World Pharma Today Twitter Page Weekly Newsletter
Click here to subscribe to our Magazine
CPHI China 2017
Top Latest Press Releases
HedgePath Announces granting of Type-C for positive clinical trial update

HedgePath Announces granting of Type-C request by FDA and provides positive clinical trial update

HedgePath Pharmaceuticals, Inc , a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer.


Acasti Pharma and CordenPharma Announce Large Scale Production of CaPrewith Manufacturing Process

Acasti Pharma Inc announced the achievement of a major corporate milestone by manufacturing the first cGMP batches of CaPre, Acasti omega-3 pharmaceutical product candidate, produced...


AcelRx Pharmaceuticals ZALVISO Recognized for Innovative Design with Prestigious Red Dot Award

AcelRx Pharma announced that ZALVISO (sufentanil sublingual tablet system) has been selected for a Red Dot Award in the category of Product Design Life Sciences and Medicine.


imange on World Pharma Today e-newsletter Interview

In an Interview with
Joe Zhou, V.P/CFO,
Reed Sinopharm Exhibitions

This Interview was taken by World Pharma Today at the National Convention and Exhibition Center in Shanghai, China

Joe Zhou, V.P/CFO,
Eisai Enters and Broad Institute To Develop An Antimalarial Medicine

Eisai Enters Into Joint Research Agreement With The Broad Institute To Develop An Antimalarial Medicine

Eisai Co Ltd announced that it has entered into a new joint research agreement with the Broad Institute , a collaborative research institute which includes researchers from the MIT and Harvard University to develop a new antimalarial medicine...


ImmunoGen receives 30M dollars on license amendments with Sanofi

ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer announced that the Company and an affiliate of Sanofi have amended their license agreements...


OBI Pharma to develop OBI-3424 a potential treatment of cancers expressing AKR1C3

OBI Pharma announced an agreement with Threshold Pharmaceuticals, Inc. to acquire TH3424, a first-in-class novel small-molecule prodrug...


Featured Events Featured Events


6 th September 2017, Queen Sirikit National Convention Centre (QSNCC), Bangkok, Thailand 
Organisers: Messe Duesseldorf Asia
Contact: (65) 6332 9620
E: medicalfair-thailand@mda.com.sg
W: www.medicalfair-thailand.com

Nordic Life Science Days 2017
12th September 2017, Medicon Valley
Organisers: Bionordic 
Contact: 33 (0) 608 804 515
E: olivier.duchamp@bionordic.com
W: www.nlsdays.com

Medical Fair Thailand 2017

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here


For the latest visit: www.worldpharmatoday.com

World Pharma Today